No other family members were available for examination, but medical history unraveled that the proband’s father who suffered from end-stage renal disease was treated in a different facility with bilateral intra-vitreous anti-VEGF injections. The gene discussed is VEGFA; the disease is stage 5 chronic kidney disease.